Simulating transmission scenarios of the Delta variant of SARS-CoV-2 in Australia
暂无分享,去创建一个
[1] N. Geard,et al. Risk mapping for COVID-19 outbreaks in Australia using mobility data , 2020, Journal of the Royal Society Interface.
[2] E. Nsoesie,et al. Sensitivity Analysis of an Individual-Based Model for Simulation of Influenza Epidemics , 2012, PloS one.
[3] Mikhail Prokopenko,et al. Interfering with influenza: nonlinear coupling of reactive and static mitigation strategies , 2020, Journal of the Royal Society Interface.
[4] Oliver M. Cliff,et al. Urbanization affects peak timing, prevalence, and bimodality of influenza pandemics in Australia: Results of a census-calibrated model , 2018, Science Advances.
[5] Anne Kimball,et al. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.
[6] Mikhail Prokopenko,et al. Investigating Spatiotemporal Dynamics and Synchrony of Influenza Epidemics in Australia: An Agent-Based Modelling Approach , 2018, Simul. Model. Pract. Theory.
[7] Mikhail Prokopenko,et al. Creating a surrogate commuter network from Australian Bureau of Statistics census data , 2018, Scientific Data.
[8] Alessandro Vespignani,et al. Comparing large-scale computational approaches to epidemic modeling: Agent-based versus structured metapopulation models , 2010, BMC infectious diseases.
[9] Ross J. Harris,et al. Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis , 2021, BMJ.
[10] Mikhail Prokopenko,et al. Modelling transmission and control of the COVID-19 pandemic in Australia , 2020, Nature communications.
[11] Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications , 2020, European Journal of Epidemiology.
[12] Estimating the impact of control measures to prevent outbreaks of COVID-19 associated with air travel into a COVID-19-free country , 2021, Scientific reports.
[13] C. C. Kerr,et al. Modelling the impact of reducing control measures on the COVID-19 pandemic in a low transmission setting , 2020, medRxiv.
[14] C. Macken,et al. Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[15] Mark Stevenson,et al. The probability of the 6‐week lockdown in Victoria (commencing 9 July 2020) achieving elimination of community transmission of SARS‐CoV‐2 , 2020, The Medical journal of Australia.
[16] Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.
[17] M. van Boven,et al. Controlling the pandemic during the SARS-CoV-2 vaccination rollout , 2021, Nature Communications.
[18] J. Kaldor,et al. Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic , 2020, The Medical journal of Australia.
[19] World Health Organization,et al. Calibrating Long-Term Non-Pharmaceutical Interventions for COVID-19: Principles and Facilitation Tools , 2020 .
[20] C. Dalton,et al. Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study , 2020, The Lancet Child & Adolescent Health.
[21] P. Austin,et al. Effectiveness of COVID-19 vaccines against variants of concern, Canada , 2021, medRxiv.
[22] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[23] Joel C. Miller. Spread of infectious disease through clustered populations , 2008, Journal of The Royal Society Interface.
[24] Lucie Abeler-Dörner,et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing , 2020, Science.
[25] J. Lopez Bernal,et al. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. Reply. , 2021, The New England journal of medicine.
[26] Hannah R. Meredith,et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application , 2020, Annals of Internal Medicine.
[27] C. Viboud,et al. Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study , 2020, BMJ.
[28] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[29] M. Prokopenko,et al. Revealing COVID-19 Transmission by SARS-CoV-2 Genome Sequencing and Agent Based Modelling , 2020, bioRxiv.
[30] A modelling analysis of the effectiveness of second wave COVID-19 response strategies in Australia , 2021, Scientific reports.
[31] M. V. Van Kerkhove,et al. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[32] L. Luo,et al. Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 — Guangdong Province, China, May–June 2021 , 2021, China CDC weekly.
[33] N. Andrews,et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 variant , 2021, medRxiv.